ArticleActa pharmaceutica Sinica. B2021

Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2.

Haiyan Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.